Combination Therapy of Gefitinib and Korean Herbal Medicines Could be a Beneficial Option for Patients with Non-Small-Cell Lung Cancer

• Main Authors: Kangwook Lee (Author), Yoon-sik Kim (Author), Chang-Gue Son (Author), Jung-Hyo Cho (Author), Hwa-Seung Yoo (Author), Jonghoon Lee (Author), Juyoung Ryu (Author), Namhun Lee (Author)
• Format: Book
• Published: Korean Pharmacopuncture Institute, 2016-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Abstract Lung cancer has a high mortality rate and is often diagnosed at the metastatic stage. Gefitinib is a targeted molecular therapeutic drug used to treat patients with non-small-cell lung cancer (NSCLC). Korean herbal medicines may also have therapeutic efficacy against lung cancer, r...